RxDoctor Payments Data

Mark Pomaranski, MD

MOHS-Micrographic Surgery · Traverse City, MINPI 1962511097

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Novartis at 27.9% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in MI, where the typical reported total is $1,792.

$1,721in general payments, 2019–2025

Across 86 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$481
  • AbbVie$360
  • Sanofi$130
  • Johnson & Johnson$125
  • Lilly USA, LLC$109
  • Sun Pharmaceutical Industries Inc.$108
  • plus $409 from 10 others

What the payments were for

  • Food & beverage$1,721100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,721 in reported general payments places this provider in the 45th percentile of 30 mohs-micrographic surgery providers in Michigan.

See all mohs-micrographic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$437,220
Medicare patients
386
Services billed
1,307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin88$357

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Traverse City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →